DNATRIX
DNAtrix is a Texas-based company developing modified viruses for the treatment of the most aggressive forms of cancer. The company’s initial focus is on glioblastoma, a devastating brain tumor that is currently incurable. Since viruses are already good at killing cells, scientists have harnessed this ability by modifying a common cold virus so that it targets and kills cancer cells selectively. More than 35 patients have been treated with the cancer-killing virus, called DNX-2401, with excelle... nt early results. Company’s lead product, DNX-2401, is the culmination of more than a decade of scientific and clinical research and is the most potent and effective oncolytic virus delivered to human brain tumors to date. DNAtrix is also working to expand its platform technology for treating other cancers, including brain metastases, ovarian and pancreatic cancer. Targeted cancer-killing viruses such as DNX-2401 represent an important new weapon in the fight against cancer.
DNATRIX
Social Links:
Industry:
Biotechnology Health Care Medical
Founded:
2005-01-01
Address:
Houston, Texas, United States
Country:
United States
Website Url:
http://www.dnatrix.com
Total Employee:
11+
Status:
Active
Contact:
7137156826
Email Addresses:
[email protected]
Total Funding:
57.08 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Google Universal Analytics Apache Microsoft Exchange Online Office 365 Mail
Similar Organizations
Asklepios BioPharmaceutical
Asklepios BioPharmaceutical is a biotechnology company developing adeno-associated virus (AAV) gene therapies for genetic disorders.
Rakuten Medical
Rakuten Medical is a Bio-technology Company.
CEL-SCI
CEL-SCI is a biotechnology company developing immunotherapy products for the treatment of cancer and other infectious diseases.
Effcon MXR
Effcon MXR is a biotechnology company developing a once-a-day version of a drug used to treat glaucoma.
ORIG3N
ORIG3N is a biotechnology company developing breakthrough treatments for rare genetically inherited diseases.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
Texas HALO Fund
Texas HALO Fund investment in Convertible Note - DNAtriX
U.S. Food and Drug Administration
U.S. Food and Drug Administration investment in Grant - DNAtriX
Targeted Technology Fund
Targeted Technology Fund investment in Series B - DNAtriX
DFJ Mercury
DFJ Mercury investment in Series B - DNAtriX
Texas HALO Fund
Texas HALO Fund investment in Series B - DNAtriX
Morningside Venture Investments
Morningside Venture Investments investment in Series B - DNAtriX
Cancer Prevention and Research Institute of Texas
Cancer Prevention and Research Institute of Texas investment in Grant - DNAtriX
DFJ Mercury
DFJ Mercury investment in Debt Financing - DNAtriX
DFJ Mercury
DFJ Mercury investment in Debt Financing - DNAtriX
DFJ Mercury
DFJ Mercury investment in Debt Financing - DNAtriX
Key Employee Changes
| Date | New article |
|---|---|
| 2021-09-14 | DNAtrix Announces the Appointment of David Liebowitz, M.D., Ph.D., as Chief Medical Officer |
Official Site Inspections
http://www.dnatrix.com Semrush global rank: 4.27 M Semrush visits lastest month: 2.72 K
- Host name: 104.21.87.74
- IP address: 104.21.87.74
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "DNAtriX"
DNAtriX - Crunchbase Company Profile & Funding
Organization. DNAtriX . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... DNAtrix is a Texas-based company developing …See details»
DNAtrix, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
DNAtrix is also working to expand their technology to treat other types of cancer, including brain metastases, ovarian, and pancreatic cancer. These targeted cancer-killing viruses represent a …See details»
DNAtriX Org Chart - The Org
Explore DNAtriX's org chart, teams, open roles, and company details. View executives, board members, related companies, and more.See details»
DNATRIX, INC. Company Profile | Carlsbad, CA - Dun & Bradstreet
Added by DNATRIX, INC. This information is updated and provided by DNATRIX, INC. The content available on the D&B Business Directory is provided "as-is" and "as-available" and …See details»
DNAtrix Company Profile | Management and Employees List
DNAtrix Profile and History. DNAtrix is a privately held biotech company developing virus-driven immunotherapies to treat cancer. Its proprietary adenovirus platform is based on an …See details»
DNAtrix | VentureRadar
DNAtrix is a company developing modified viruses for the treatment of the most aggressive forms of cancer. Since viruses are already efficient at killing cells, scientists have harnessed this …See details»
DNAtrix Company Profile 2024: Valuation, Funding & Investors
DNAtrix was founded in 2005. Where is DNAtrix headquartered? DNAtrix is headquartered in Houston, TX. What is the size of DNAtrix? DNAtrix has 13 total employees. What industry is …See details»
DNAtrix Company Overview, Contact Details & Competitors | LeadIQ
DNAtrix. Biotechnology Research California, United States 11-50 Employees. DNAtrix is a privately held biotech company developing virus-driven immunotherapies to treat cancer. Its …See details»
DNAtriX Company Profile - Office Locations, Competitors ... - Craft
DNAtrix is a biotechnology company that provides virus-driven immunotherapies for cancer. It develops DNX-2401 (tasadenoturev) and DNX-2440, oncolytic adenoviruses that selectively …See details»
DNAtrix - Overview, News & Similar companies | ZoomInfo.com
Nov 22, 2021 Who is DNAtrix. DNAtrix is a privately held biotech company developing virus-driven immunotherapies to treat cancer. Its proprietary adenovirus platform is based o n an …See details»
DNAtriX - Crunchbase
DNAtriX is a biotechnology company developing an oncolytic virus platform for treating malignant glioma.See details»
DNAtriX - Contacts, Employees, Board Members, Advisors & Alumni
Organization. DNAtriX . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. ... DNAtriX has 8 current employee profiles, …See details»
DNAtrix - LinkedIn
DNAtrix is a privately held biotech company developing virus-driven immunotherapies to treat cancer. Its proprietary adenovirus platform is based on an engineered version of the common …See details»
DNAtrix - Company Profile - Tracxn
Nov 5, 2024 DNAtrix ranks 602nd among 2379 active competitors. 862 of its competitors are funded while 545 have exited. Overall, DNAtrix and its competitors have raised over $79.6B in …See details»
DNAtrix Awarded $10.8 Million Grant by the Cancer Prevention …
Feb 24, 2014 HOUSTON--DNAtrix Inc., a biotech company focusing on the development of oncolytic viruses for cancer, announced today that it has been awarded a product …See details»
DNAtriX - Updates, News, Events, Signals & Triggers - Crunchbase
DNAtriX is a biotechnology company developing an oncolytic virus platform for treating malignant glioma.See details»
FDA GRANTS ORPHAN DRUG DESIGNATION TO DNATRIX’S DNX …
SAN DIEGO, CA. – October 7, 2014 – DNAtrix, Inc., experts in oncolytic virus development, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug …See details»
Merck and DNAtrix Announce Phase 2 Immuno-Oncology …
Oct 1, 2015 Merck (NYSE:MRK), known as MSD outside the United States and Canada, and DNAtrix today announced they have entered into an oncology clinical study collaboration to …See details»
DNAtriX - Funding, Financials, Valuation & Investors - Crunchbase
DNAtriX is funded by 5 investors. Texas HALO Fund and Targeted Technology Fund are the most recent investors. DNAtriX has a post-money valuation in the range of $50M to $100M as of …See details»
DNAtrix Announces Preclinical Data Demonstrating Anti-Tumor …
HOUSTON, Feb. 11, 2021 /PRNewswire/ -- DNAtrix, a biotech company advancing virus-driven immunotherapies for cancer, today announced preclinical data evaluating the use of DNX …See details»